Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Current Leases (2020 - 2025)

Korro Bio's Current Leases history spans 6 years, with the latest figure at $2.7 million for Q4 2025.

  • For the quarter ending Q4 2025, Current Leases rose 108.1% year-over-year to $2.7 million, compared with a TTM value of $2.7 million through Dec 2025, up 108.1%, and an annual FY2025 reading of $2.7 million, up 108.1% over the prior year.
  • Current Leases for Q4 2025 was $2.7 million at Korro Bio, down from $3.1 million in the prior quarter.
  • The five-year high for Current Leases was $3.1 million in Q3 2025, with the low at $457000.0 in Q2 2024.
  • Average Current Leases over 5 years is $1.9 million, with a median of $1.9 million recorded in 2022.
  • Year-over-year, Current Leases plummeted 78.87% in 2024 and then surged 430.63% in 2025.
  • Tracing KRRO's Current Leases over 5 years: stood at $1.7 million in 2021, then skyrocketed by 67.2% to $2.9 million in 2022, then plummeted by 31.84% to $2.0 million in 2023, then crashed by 35.51% to $1.3 million in 2024, then surged by 108.1% to $2.7 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Current Leases are $2.7 million (Q4 2025), $3.1 million (Q3 2025), and $2.4 million (Q2 2025).